Sanofi will acquire Kadmon for $9.50 per share in cash, representing a total equity value of around $1.9bn

Prostate cancer therapy now recommended for two indications within its marketing authorisation

The NHS in England will get an extra £5.4bn (€6.3bn; $7.5bn) in funding over the next six months […]

Teligent pulls ‘super potent’ topical lidocaine lot following failed stability tests nhigginsdunn Tue, 09/07/2021 – 11:46

Roche’s Polivy to hit $2.4B as doctors expect ‘significant switching’ in newly diagnosed lymphoma: analyst aliu Tue, 09/07/2021 […]

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028 esagonowsky Tue, […]

A study by the UPV/EHU-University of the Basque Country develops a simple, non-invasive tool designed to predict the […]

The team at the University of Geneva (UNIGE), Switzerland, has developed an artificial intelligence (AI) algorithm based on […]

A research team at the RIKEN Center for Emergent Matter Science (CEMS) in Japan has developed a diagnostic […]

Scientists from the MPI for Medical Research and colleagues have engineered synthetic exosomes that regulate cellular signaling during […]